Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2023
Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023G Curigliano, H J Burstein, M Gnant, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2010
SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancerE L Mayer, S Dhakil, T Patel, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2025
Tailoring treatment to cancer risk and patient preference: the 2025 St Gallen International Breast Cancer Consensus Statement on individualizing therapy for patients with early breast cancerH J Burstein, G Curigliano, M Gnant, et al.Psycho-Oncology|January 2, 2017
Experts' perspectives on the role of medical marijuana in oncology: A semistructured interview studyI M Braun, F L Meyer, J J Gagne, et al.European Journal of Cancer (Oxford, England : 1990)|February 18, 2011
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809C L Shapiro, S Halabi, V Hars, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2009
Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimensK L Blackwell, M D Pegram, E Tan-Chiu, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2019
Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019H J Burstein, G Curigliano, S Loibl, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
Phase I study of Doxil and vinorelbine in metastatic breast cancerH J Burstein, M J Ramirez, W P Petros, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Docetaxel administered on a weekly basis for metastatic breast cancerH J Burstein, J Manola, J Younger, et al.Breast Cancer Research and Treatment|May 7, 2013
A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancerN U Lin, D S Seah, R Gelman, et al.Pageof 5